Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study identifies fat-secreted protein linked to insulin resistance

21.07.2005


Findings show new link between obesity and type 2 diabetes



A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) has shown that a protein found in fat cells is a newly discovered cause of insulin resistance, establishing a previously unidentified molecular link between obesity and type 2 diabetes and offering a potential new target for the development of drugs to treat diabetes. The findings appear in the July 21, 2005, issue of the journal Nature.

According to senior author Barbara B. Kahn, MD, Chief of the Division of Endocrinology, Diabetes, and Metabolism at BIDMC, these findings in both mice and humans represent the first evidence that elevated levels of retinol binding protein 4 (RBP4) play a key role in the development of insulin resistance, a primary risk factor for diabetes.


"Being resistant to insulin is one of the major causes of diabetes," says Kahn, who is also a Professor of Medicine at Harvard Medical School. "And even in the absence of diabetes, insulin resistance is a major risk factor for heart disease and early mortality."

Produced by the pancreas, the hormone insulin functions to help cells throughout the body take in glucose and convert the simple sugar to energy. In individuals who are resistant to insulin, the body’s muscle, fat and liver cells are unable to properly respond to the hormone, resulting in a build-up of glucose and insulin in the blood which, in turn, can lead to the development of diabetes and cardiovascular disease.

Earlier work in Kahn’s lab had focused on understanding the role of a glucose transporter protein called GLUT4 in the development of insulin resistance. Knowing that downregulation of GLUT4 expression in fat tissue is an almost universal feature of insulin-resistant states (including obesity, type 2 diabetes and the metabolic syndrome), previous members of Kahn’s lab developed two transgenic mouse models: One with fat-cell specific overexpression of GLUT4 and one with fat-cell specific reduction of GLUT4.

They found that the mice with overexpression of GLUT4 clearly demonstrated enhanced glucose tolerance and insulin sensitivity while, in contrast, the mice with reduced GLUT4 expression in fat tissue became insulin resistant and had an increased risk of developing diabetes.

"The results suggested that manipulating GLUT4 in adipose tissue affects whole body insulin sensitivity, very possibly through the secretion of proteins from fat cells," explains Kahn. "We therefore, measured the known fat-secreted molecules, including leptin, resistin and adiponectin, but found that in all cases, the levels were normal."

The study’s investigators, led by Qin Yang, MD, PhD, and Timothy Graham, MD, in Kahn’s lab, then conducted a global microarray analysis to identify a novel protein. "This led to our discovery of RBP4," says Kahn.

Further investigation found that both genetic and pharmacologic elevation of RBP4 can cause insulin resistance and that genetic and pharmacologic decrease of the protein in insulin-resistant states would ameliorate the condition. In humans with obesity or type 2 diabetes, the amount of excess RBP4 in the blood correlates with the severity of insulin resistance.

Until now, the sole function of RBP4 known to scientists was to deliver retinol (vitamin A) to tissues. With these new findings, it appears that this abundant transport (carrier) protein may have another function and that the metabolism of vitamin A or related compounds could possibly have some indirect impact on insulin action.

"There is a rapidly increasing epidemic of obesity and Type 2 diabetes in the Western world," says Kahn. "And, of particular concern, these conditions are becoming more common, not only in adults, but also in children and adolescents.

"It is, therefore, clear that more effective treatment strategies are needed to prevent and treat diabetes. RBP4 could prove to be a novel target for developing anti-diabetic therapies."

Bonnie Prescott | EurekAlert!
Further information:
http://www.bidmc.harvard.edu

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>